Review Article on Aspirin for prevention of cancer-A potential!

Journal Title: Journal of Biomedical and Pharmaceutical Research - Year 2017, Vol 6, Issue 4

Abstract

Cancer has been a worldwide threat now with millions of cases of morbidity and mortality owing to it. According to the World Health Organization (WHO), cancer accounted for 8.2 million deaths worldwide by 2012 and its prevalence is predicted to increase in the next decade. There are, however, new data that reinforce the notion that low-dose aspirin intake may also help to prevent cancer and prevent the multiplying of cancer cells. Over the last few years, many studies have combated or supported the substantiation of the relationship between aspirin and cancer that have awakened the interest of researchers in this area. Many studies with follow-up period as long as 20 years have been carried out to analyze the effect that regular use of low-dose aspirin (75-300mg) can have on cancer prevention, especially colorectal cancer and the results have been promising. With the comprehensive analysis of risks and benefits and the linking evidences showing that aspirin, at low doses, can lower the risk of developing colorectal cancer by 40%, the U.S. Preventive Services Task Force (USPSTF) in 2015 released a draft recommendation around the use of aspirin to help prevent cardiovascular disease and colorectal cancer. The guidance was later released in April 2016. By far, there have been evidences for both COX-dependent and COX-independent mechanisms in aspirin cancer prevention. Based on the data that we have from various RCT’s and pharmacovigilance sources, the safety profile of aspirin looks reasonably good with the most commonly reported adverse event being Gastrointestinal bleeding. Although some clinical trials have shown that the risk may only be modest it however, cannot be ignored

Authors and Affiliations

Riju Pathak| Pharm.D, Krupanidhi College of Pharmacy, Chikka Bellandur, Carmellaram Post, Varthur Hobli, Bangalore-35, Patel Trushitkumar B| Pharm.D, Krupanidhi College of Pharmacy, Chikka Bellandur, Carmellaram Post, Varthur Hobli, Bangalore-35

Keywords

Related Articles

Prescribing Pattern of Antibiotics in Intensive Care Unit of a Tertiary Care Teaching Hospital

Antibiotics are the most commonly administered drugs in ICU. By optimizing the use of antibiotics within ICU, patient outcomes are improved, better initial antibiotics administration is provided, and the chance of furthe...

SENSITIVITY PATTERN OF METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS ISOLATED FROM SURGICAL SITE INFECTIONS

Surgical site infections are an important cause of health care associated infections among surgical patients. Patients who develop surgical site infections have longer hospital stays, more expensive hospitalizations, and...

A COMPARATIVE EVALUATION OF FLEXURAL FATIGUE RESISTANCE OF PROTAPER NEXT AND PROFILE VORTEX: AN IN-VITRO STUDY.

Background: Introduction of nickel titanium file system for root canal therapy has changed the conventional approach but instrument fracture in curved and narrow root canal still remains a challenge for operator. Aim & o...

EVALUATION OF PLATELET COUNT AND PLATELET INDICES IN PATIENTS WITH ACUTE MALARIA IN SHENDI LOCALITY

Background: Malaria is the commonest cause of morbidity in Africa. This study describes altered platelet count and platelet indices in patients with acute malaria caused by Plasmodium falciparum, Plasmodium vivax and pla...

PHYTOCHEMICAL STUDIES AND IN VIVO ANTIOXIDANT ACTIVITY OF TWO LAVANDULA SPECIES (LAMIACEAE) AGAINST STREPTOZOTOCIN INDUCED OXIDATIVE STRESS IN ALBINO RATS

Phytochemical studies of two Lavandula species namely L. dentata L. and L. angustifolia Mill. (Lamiaceae) cultivated in Egypt was carried out to subsist positive diagnostic indices for the research of their monographs as...

Download PDF file
  • EP ID EP4151
  • DOI -
  • Views 397
  • Downloads 23

How To Cite

Riju Pathak, Patel Trushitkumar B (2017). Review Article on Aspirin for prevention of cancer-A potential!. Journal of Biomedical and Pharmaceutical Research, 6(4), 31-35. https://europub.co.uk/articles/-A-4151